Helius Medical Technologies (HSDT) Projected to Post Quarterly Earnings on Wednesday

Helius Medical Technologies (NASDAQ:HSDT) is projected to release its earnings data before the market opens on Wednesday, March 26th. Analysts expect Helius Medical Technologies to post earnings of ($0.94) per share and revenue of $0.10 million for the quarter.

Helius Medical Technologies Stock Down 8.1 %

Shares of HSDT opened at $0.40 on Tuesday. The firm has a market cap of $1.47 million, a price-to-earnings ratio of -0.06 and a beta of 1.62. The company’s fifty day moving average is $0.57 and its 200-day moving average is $0.60. Helius Medical Technologies has a 12 month low of $0.37 and a 12 month high of $7.19.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.